SUMO-1 modification of the acute promyelocytic leukaemia protein PML: Implications for nuclear localisation

Journal of Cell Science

Volumn 112, Issue 3, 1999, Pages 381-393

  Duprez, Estelle ^a,c   Saurin, Andrew J ^a   Desterro, Joana M ^b   Lallemand Breitenbach, Valerie ^c   Howe, Kathy ^d   Boddy, Michael N ^a,e   Solomon, Ellen ^d   De Thé, Hugues ^c   Hay, Ronald T ^b   Freemont, Paul S ^a  

^a IMPERIAL CANCER RESEARCH FUND   (United Kingdom)

^b UNIVERSITY OF ST ANDREWS   (United Kingdom)

^c SAINT LOUIS HOSPITAL   (France)

^d GUY S HOSPITAL   (United Kingdom)

^e SCRIPPS RESEARCH INSTITUTE   (United States)

Author keywords

Acute promyelocytic leukaemia; Modification; PML; SUMO 1; UBC9; Ubiquitin like

Indexed keywords

HYBRID PROTEIN; NUCLEAR PROTEIN;

AMINO ACID SEQUENCE; ANIMAL CELL; ARTICLE; CELL NUCLEUS; CONSENSUS SEQUENCE; HUMAN; HUMAN CELL; NONHUMAN; PRIORITY JOURNAL; PROTEIN MODIFICATION; PROTEIN PROTEIN INTERACTION;

CONSENSUS SEQUENCE; FLUORESCENT ANTIBODY TECHNIQUE; HUMANS; LIGASES; MODELS, BIOLOGICAL; MOLECULAR SEQUENCE DATA; MUTAGENESIS, SITE-DIRECTED; NEOPLASM PROTEINS; NUCLEAR LOCALIZATION SIGNALS; NUCLEAR MATRIX; NUCLEAR PROTEINS; RECOMBINANT FUSION PROTEINS; SEQUENCE ALIGNMENT; SUMO-1 PROTEIN; TRANSCRIPTION FACTORS; TRANSLOCATION, GENETIC; TUMOR CELLS, CULTURED; TUMOR SUPPRESSOR PROTEINS; UBIQUITIN-CONJUGATING ENZYMES; UBIQUITINS;

ANIMALIA;

EID: 0033034749     PISSN: 00219533     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (47)

1. Boddy, M. N., Howe, K., Etkin, L. D., Solomon, E. and Freemont, P. S. (1996). PIC-1, a novel ubiquitin-like protein which interacts with the PML component of a multiprotein complex that disrupted in acute promyelocytic leukemia. Oncogene 13, 971-982.
2. Boddy, M. N., Duprez, E., Borden, K. L. B. and Freemont, P. S. (1997). Surface residue mutations of PML RING finger domain alter the formation of nuclear matrix-associated PML bodies. J. Cell Sci. 110, 2197-2205.
3. Borden, K. L. B., Boddy, M. N. Lally, J., O'Reilly, N. J., Martin, S., Howe, K., Solomon, E. and Freemont, P. S. (1995). The solution structure of the RING finger domain from the acute promyelocytic leukemia protooncoprotein PML. EMBO J. 14, 1532-1541.
4. Borden, K. L. B., Lally, J. M., Martin, S. R., O'Reilly, N. J., Solomon, E. and Freemont, P. S. (1996). In vivo and in vitro characterisation of the B1 and B2 zinc-binding domains from the acute promyelocytic leukaemia proto-oncoprotein PML. Proc. Natl. Acad. Sci. USA 93, 1601-1606.
5. Chang, K.-S., Fan, Y.-H., Andreeff, M., Liu, J. and Mu, Z-M. (1995). The PML gene encodes a phosphoprotein associated with the nuclear matrix. Blood 85, 3646-3653.
6. Conti, E., Uy, M., Leighton, L., Blobel, G. and Kuriyan, J. (1998). Crystallographic analysis of the recognition of a nuclear localisation signal by the nuclear import factor karyopherin alpha. Cell 94, 193-204.
7. Dalton, S. and Treisman, R. (1992). Characterization of SAP-1, a protein recruited by serum response factor to the C-Fos serum response element. Cell 68, 597-612.
8. Daniel, M. T., Koken, M., Romagne, O., Barbey, S., Bazarbachi, A., Stadler, M., Guillemin, M. C., Degos, L., Chomienne, C. and de Thé, H. (1993). PML protein expression in hematopoietic and acute promyelocytic leukaemia cells. Blood 82, 1858-1867.
9. Desterro, J. M., Thomson, J. and Hay, R. T. (1997). Ubc9 conjugates SUMO but not ubiquitin. Febs Lett. 417, 297-300.
10. Desterro, J. M., Rodriguez, M. S. and Hay, R. T. (1998). SUMO-1 modification of IκBα inhibits NF-κB activation. Mol. Cell 2, 233-239.
11. Dyck, J. A., Maul, G. G., Miller, W. H., Chen, J. D., Kakizuka, A. and Evans., R. M. (1994). A novel macromolecular structure is a target of the promyelocyte-retinoic acid receptor oncoprotein. Cell 76, 333-343.
12. Everett, R., Freemont, P., Saitoh, H., Dasso, M., Orr, A., Kathoria, M. and Parkinson, J. (1998). The disruption of ND10 during herpes simplex virus infection correlates with the Vmw110- and proteasome-dependent loss of several PML isoforms. J. Virol. 72, 6581-6591.
13. Fagioli, M., Alcalay, M., Tomassoni, L., Ferrucci, P. F., Mencarelli, A., Riganelli, D., Grignani, F., Pozzan, T., Nicoletti, I., Grignani, F. and Pelicci, G. (1998). Cooperation between the RING+B1-B2 and coiled-coil domains ot PML is necessary for its effects on cell survival. Oncogene 16, 2805-2913.
14. Goddard, A. D., Borrow, J., Freemont, P. and Solomon, E. (1991). Characterization of a zinc finger gene disrupted by the t(15;17) in acute promyelocytic leukaemia. Science 254, 1371-1374.
15. Goddard, A. D., Yuan, J. Q., Fairbairn, L., Dexter, M., Borrow, J., Kozak, C. and Solomon, E. (1995). Cloning of the murine homolugueue of the leukaemia-associated PML gene. Mamm. Genome 6, 732-737
16. Gong, L., Kamitani, Fujise, K., Caskey, L. S. and Yeh, E. T. H. (1997). Preferential modification of nuclear proteins by a novel ubiquitin-like molecule. J. Biol. Chem. 272, 14001-14004.
17. Görlich, D. (1998). Transport into and out of the cell nucleus. EMBO J. 17, 2721-2727.
18. Grimwade, D. and Solomon, E. (1997). Characterisation of the PML/RARA rearrangement associated with t(15;17) acute promyelocytic leukaemia. Curr. Topics Microbiol. Immunol. 220, 81-112.
19. Hodges, M., Tissot, C., Howe, K., Grimwade, D. and Freemont, P. S. (1998a). Structure. Organisation, and Dynamics of Promyelocytic Leukaemia Protein Nuclear Bodies. Am. J. Hum. Genet. 63, 297-304
20. Hodges, M., Tissot, C. and Freemont, P. S. (1998b). Protein regulation: Tag wrestling with relatives of ubiquitin. Curr. Biol. 8, R749-R752.
21. Johnson, E. S. and Blobel, G. (1997a). UBC9p is the conjugating enzyme for the ubiquitin-like protein Smt3p. J. Biol. Chem. 272, 26799-26802.
22. Johnson, E. S., Schwienhorst, I., Dohmen, R. J. and Blobel, G. (1997b). The ubiquitin-like protein Smt3p is activated for conjugation to other proteins by an Aos1p/Uba2p heterodimer. EMBO J 16, 5509-5519.
23. Kamitani, T., Nguyen, H. P. and Yeh, E. T. H. (1997). Preferential modification of nuclear proteins by a novel ubiquitin-like molecule. J. Biol. Chem. 272, 14001-14004.
24. Kamitani, T., Nguyen, H. P., Kito, K., Fukuda-Kamitati, T. and Yeh, E. T. H. (1998). Covalent modification of PML by the sentrin family of ubiquitin-like proteins. J. Biol. Chem. 273, 3117-3120.
25. Kastner, P., Perez, A., Lutz, Y., Rochette-Egly, C., Gaub, M. P., Durand, B, Lanotte, M., Berger, R. and Chambon, P. (1992). Structure, localization and transcriptional properties of two classes of retinoid acid receptor a (RAR-α) fusion proteins in acute promyelocytic leukemia (APL). Structural similarities with a new family of oncoproteins. EMBO J. 11, 629-642.
26. Koken, M. H., Puvion-Dutilleul, F., Guillemin, M. C., Viron, A., Linares-Cruz, G., Stuurman, N., de Jong, L. Szostecki, C., Calvo, F., Chomienne, C., Degos, L., Puvion, E. and de Thè, H. (1994). The t(15; 17) translocation alters a nuclear body in a retinoic acid-reversible fashion. EMBO J. 13, 1073-1083.
27. Le, X.-F., Yang, P. and Chang, K.-S. (1996). Analysis of the growth and transformation suppressor domains of promyelocytic leukemia gene, PML. J. Biol. Chem. 271, 130-135.
28. Le, X.-F., Vallian, S., Mu, Z. M., Hung, M. C. and Chang, K.-S. (1998). Recombinant PML adenovirus suppresses growth and tumorigenicity of human breast cancer cells by inducing G1 cell cycle arrest and apoptosis. Oncogene 16, 1839-1849.
29. Liu, J. H., Mu, Z. M. and Chang, K. S. (1995). PML suppresses oncogenic transformation of N1H-3T3 cells by activated neu. J. Exp. Med. 181, 1965-1973.
30. Mahajan, R., Delphin, C., Guan, T., Gerace, L. and Melchior, F. (1997). A small ubiquitin-related polypeptide involved in targeting RanGAP1 to nuclear pore complex protein RanBP2. Cell 88, 97-107.
31. Mahajan, R., Gerace, L. and Melchior, F. (1998). Molecular characterisation of the SUMO-1 modification of RanGAP1 and its role in nuclear envelope association. J. Cell Biol. 140, 259-270.
32. Matunis, M. J., Coutavas, E. and Blobel, G. (1996). A novel ubiquitin-like modification modulates the partitioning of the Ran-GTPase-activating protein RanGAP1 between the cytosol and the nuclear pore complex. J. Cell Biol. 135, 1457-1470.
33. Mu, Z.-M., Chin, K.-V., Liu, J-H., Lozano, G. and Chang, K-S. (1994). PML, a growth supressor disrupted in acute promyelocytic leukemia. Mol. Cell Biol. 14, 6858-6867.
34. Müller, S., Matunis, M. J. and Dejean, A. (1998). Conjugation with the ubiquitin-related modifier SUMO-1 regulates the partitioning of PML within the nucleus. EMBO J. 139, 1621-1634.
35. Mullis, K., Faloona, F., Scharf, S., Saiki, R., Horn, G. and Erlich, H. (1986). Specific enzymatic amplification of DNA in vitro - the polymerase chain reaction. Cold Spring Harbor Symp. 51, 263-273.
36. Okura, T., Gong, L., Kamitaniji, T., Wadai, T., Okurai, I., Weii, C.-F., Chang, H-M. and Yeh, E. T. H. (1996). Protection against Fas/APO1- and tumor necrosis factor-mediated cell death by a novel protein, Sentrin, J. Immunol. 157, 4277-4281.
37. Perez, A., Kastner, P., Sethi, S., Lutz Y., Reibel, C. and Chambon, P. (1993). PML-RARα homodimers: distinct DNA binding properties and heterodimeric interactions with RXR. EMBO J. 12, 3171-3182.
38. Quignon, F., De Bels, F., Koken, M., Feunteun, J., Ameisen, J. C. and de Thé, H. (1998). PML induces a novel caspase-independent death process. Nature Genet. 20, 259-265.
39. Reddy, B. A., Freemont, P. S. and Etkin, L. D. (1992). A novel zinc finger coiled-coil domain in a family of nuclear proteins. Trends Biochein. Sci. 17, 344-345.
40. Saitoh, H. S., D. B., Shiomi, T., Pu, R. T., Nishimoto, T., Mohun, T. J. and Dasso, M. (1998). Ubc9p and the conjugation of SUMO-1 to RanGAP 1 and RanBP2. Curr. Biol. 8, 121-124.
41. Saurin, A. J., Borden, K. L. B., Boddy, M. N. and Freemont, P. S. (1996). Does this have a familiar RING ? Trends Biochem. Sci. 21, 208-213.
42. Seufert, W., Futcher, B. and Jentsh, S. (1995). Role of a ubiquitin-conjugating enzyme in degradation of S- and M-phase cyclins. Nature 373, 78-81.
43. Shen, Z., Pardington-Purtymun, P. E., Comeaux, J. C., Moyzis, R. K. and Chen, D. J. (1996). UBL1, a human ubiquitin-like protein associating with human RAD51/RAD52 proteins. Genomics 36, 271-279.
44. Skinner, P. J., Koshy, B. T., Cummings, C. J., Klement, I. A., Helin, K., Servadio, A., Zoghbi, H. Y. and Orr, H. T. (1997). Ataxin-1 with an expanded glutamine tract alters nuclear matrix-associated structures. Nature 389, 971-974.
45. Sternsdorf, T., Jensen, K. and Will, H. (1997). Evidence for covalent modification of the nuclear dot-associated protein PML and SP100 by PIC1/SUMO-1. J. Cell Biol. 139, 1621-1634.
46. Weis, K., Rambaud, S., Lavau, C., Jansen, J., Carvalho, T., Carmo-Fonseca, M., Lamond, A. and Dejean, A. (1994). Retinoic acid regulates aberrant nuclear localization of PML-RARα in acute promyelocytic leukemia cells. Cell 76, 345-356.
47. Zhu, J., Koken, M. H. M., Quignon, F., Chelbi-Alix, M. K., Degos, L., Wang, Z. Y., Chen, Z. and de Thé, H. (1997). Arsenic-induced PML targeting onto nuclear bodies: Implication for the treatment of acute promyelocytic leukemia. Proc. Natl. Acad Sci. USA 94, 3978-3983.